Investigation of hepatitis G virus prevalence in hemodialysis patients and blood donors in Denizli, Turkey;Denizli'de hemodiyaliz hastalarιnda ve kan donörlerinde hepatit G virus prevalansιnιn araştιrιlmasι

Mikrobiyoloji Bulteni

Volumn 42, Issue 4, 2008, Pages 617-625

  Yilmaz Hanci, Sevgi ^a   Cevahir, Nural ^b   Kaleli, Ilknur ^b   Hanci, Volkan ^c  

^a Zonguldak Devlet Hastanesi   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Blood donor; GBV C HGV; Haemodialysis; RT PCR; Turkey

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HEPATITIS G VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PREVALENCE; RENAL REPLACEMENT THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC); VIRUS HEPATITIS; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TURKEY;

EID: 55949107871     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pahsa A. Yeni hepatit viruslarι, s: 22-42. Tabak F, Balik I, Tekeli E (ed), Viral Hepatit 2005. 2005, 1. baskι. Orhan Matbaasι, Istanbul.
2. Anastassopoulou CG, Paraskevis D, Tassopoulos NC, et al. Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece. J Med Virol 2000; 61: 319-26.
3. Li G, Ma H-H, Lau GKK, et al. Prevalence of hepatitis G virus infection and homology of different viral strains in Southern China. World J Gastroenterol 2002; 8: 1081-7.
4. Erensoy S. Hepatit etyolojisinde sorgulanan yeni viruslar, s: 270-85. Balik I, Tekeli E (ed), Viral Hepatit 2003. 2002, Viral Hepatitle Savaşim Derneǧi, Ankara.
5. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90.
6. Schröter M, Feucht H-H, Schäfer P, et al. GB Virus C/hepatitis G virus infection in hemodialysis patient: Determination of seroprevalence by a four-antigen recombinant immunoblot assay. J Med Virol 1999; 57: 230-4.
7. Hinrichsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors for hepatitis G (HGV) infection in haemodialysis patients: a multicentre study. Nephrol Dial Transplant 2002; 17: 271-75.
8. Desassis J-F, Laperche S, Girault A, et al. Prevalence of present and past hepatitis G virus infection in a French_ hemodialysis centre. Nephrol Dial Transplant 1999; 14: 2692-7.
9. Cabrerizo M, Bartolomé J, Sequer PD, et al. GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients. Kidney Int 1999; 56: 1120-8.
10. Filho RR, Carneiro ASM, Teles SA, et al. GB Virus C/hepatitis G virus infection in dialysis patients and kidney transplant recipients in central Brazil. Mem Inst Oswaldo Cruz 2004; 99: 639-43.
11. Tribi B, Oesterreicher C, Pohanka E, et al. GBV-C/HGV in hemodialysis patients: anti-E2 antibodies and GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells. Kidney Int 1998; 53: 212-6.
12. Altindis M, Aktepe OC, Cetinkaya Z, et al. TT virus and hepatitis G virus in different risk groups in Afyon. Mikrobiyol Bul 2004; 38: 61-7.
13. Ozdarendeli A, Toroman ZA, Kalkan A, et al. Prevalence and genotypes of hepatitis G virus among hemodialysis patients in Eastern Anatolia, Turkey. Med Princ Pract 2005; 14: 102-6.
14. Yavuz M, Ersoy A, Aslanhan I, et al. Kronik diyaliz hastalarinda hepatit G virus enfeksiyonu. Türk Nefroloji Diyaliz ve Transplantasyon Derg 2001; 10: 162-7.
15. Abu Odeh OR, Al-Moslih IM, Al-Jokhdar MW, et al. Detection and genotyping of GBV-C virus in the United Arab Emirates. J Med Virol 2005; 76: 534-40.
16. Handajani R, Soetjipto, Lusida MI, et al. Prevalence of GB virus C/ hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants. J Clin Microbiol 2000; 38: 662-8.
17. Brojer E, Grabarczyk P, Kryczka W, et al. Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis. J Viral Hep 1999; 6: 471-5.
18. Desai MM, Pal RB, Banker DD. GB virus C/hepatitis G virus infection in Indian blood donors and high risk groups. Transfus Apheresis Sci 2004; 30: 111-7.
19. Loureiro CL, Alonso R, Pacheco BA, et al. High prevalence of GB virus C/ hepatitis G virus genotype 3 among autochthonous Venezuelan populations. J Med Virol 2002; 68: 357-62.
20. Hitzler WE, Runkel S. Prevalence, persistence and liver enzyme levels of HGV RNA positive blood donors determined by large-scale screening and transmission by blood components. Clin Lab 2004; 50: 25-31.
21. Nordbø SA, Krokstad S, Winge P, et al. Prevalence of GB Virus C (also called hepatitis G Virus) markers in Norwegian blood donors. Clin Microbiol 2000; 38: 2584-90.
22. El-Zayadi AR, Abe K, Selim O, et al. Prevalence of GBV-C:hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. J Virol Methods 1999; 80: 53-8.
23. Pekbay A, Günaydin M, Esen Ş ve ark. Çeşitli risk gruplarι ve saǧlιklι toplumda hepatit G virusu prevalansιnιn belirlenmesi. Viral Hepatit Derg 2000; 6: 58-61.
24. Uygun A, Kadayifci A, Kubar A, et al. Insignificant role of hepatitis G virus infection in patients with liver enzyme elevations of unknow etiology. J Clin Gastroenterol 2000; 31: 73-6.
25. Kaya S, Arido-cagan BC, Demirci M. Kan vericilerinde hepatit G virus prevalansι. Infeksiyon Derg 2005; 19: 15-18.
26. Guney C, Kadayifci A, Savas MC, et al. Frequency of hepatitis G virus and transfusion-transmitted virus infection in type II diabetes mellitus. Int J Clin Pract 2005; 59: 206-9.
27. Kalkan A, Ozdarendeli A, Bulut Y, et al. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Jpn J Infect Dis 2005; 58: 222-7.
28. Gültekin F, Bakici ZM, Sezer H, et al. Hemodiyaliz hastalarinda hepatit G virus prevalansι. Türkiye Klinikleri 2007; 27: 9-12.
29. Schulte-Frohlinde E, Schmolke S, Reindl W, et al. Significance of antibodies to the recombinant E2 protein of hepatitis G virus in haemodialysis patients. J Viral Hepat 1998; 5: 341-4.